Literature DB >> 20660028

A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness.

Yanbin Dong1, Inger S Stallmann-Jorgensen, Norman K Pollock, Ryan A Harris, Daniel Keeton, Ying Huang, Ke Li, Reda Bassali, De-huang Guo, Jeffrey Thomas, Gary L Pierce, Jennifer White, Michael F Holick, Haidong Zhu.   

Abstract

CONTEXT: Vitamin D insufficiency/deficiency is commonly observed in black youth.
OBJECTIVE: The aim was to determine 25-hydroxyvitamin D [25(OH)D] in response to 2000 IU vitamin D supplementation over time; to evaluate the relation between 25(OH)D concentrations and total body fat mass by dual-energy x-ray absorptiometry; and to determine whether vitamin D supplementation improves arterial stiffness measured by pulse wave velocity (PWV).
DESIGN: We conducted a randomized, blinded, controlled clinical trial. SETTING AND PARTICIPANTS: Forty-nine normotensive black boys and girls, aged 16.3 ± 1.4 yr, were randomly assigned to either the control group (400 IU/d; n = 24) or the experimental group (2000 IU/d; n = 25).
RESULTS: Plasma 25(OH)D values at baseline and at 4, 8, and 16 wk were 34.0 ± 10.6, 44.9 ± 9.4, 51.2 ± 11.1, and 59.8 ± 18.2 nmol/liter, respectively, for the control group; and 33.1 ± 8.7, 55.0 ± 11.8, 70.9 ± 22.0, and 85.7 ± 30.1 nmol/liter, respectively, for the experimental group. The experimental group vs. the control group reached significantly higher 25(OH)D concentrations at 8 and 16 wk, respectively. Partial correlation analyses indicated that total body fat mass at baseline was significantly and inversely associated with 25(OH)D concentrations in response to the 2000-IU supplement across time. Furthermore, carotid-femoral PWV increased from baseline (5.38 ± 0.53 m/sec) to posttest (5.71 ± 0.75 m/sec) in the control group (P = 0.016), whereas in the experimental group carotid-femoral PWV decreased from baseline (5.41 ± 0.73 m/sec) to posttest (5.33 ± 0.79 m/sec) (P = 0.031).
CONCLUSION: Daily 2000 IU vitamin D supplementation may be effective in optimizing vitamin D status and counteracting the progression of aortic stiffness in black youth. Plasma 25(OH)D concentrations in response to the 2000 IU/d supplementation are negatively modulated by adiposity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20660028     DOI: 10.1210/jc.2010-0606

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  84 in total

1.  Nutrition: D-iabetes and D-eath D-efying vitamin D.

Authors:  Michael F Holick
Journal:  Nat Rev Endocrinol       Date:  2012-05-29       Impact factor: 43.330

Review 2.  Should hypertensive patients take vitamin D?

Authors:  Gregoire Wuerzner; Michel Burnier; Bernard Waeber
Journal:  Curr Hypertens Rep       Date:  2012-08       Impact factor: 5.369

3.  Effect of vitamin D3 treatment on endothelial function in obese adolescents.

Authors:  A Javed; I J Kullo; P Babu Balagopal; S Kumar
Journal:  Pediatr Obes       Date:  2015-08-14       Impact factor: 4.000

Review 4.  Vitamin D in childhood and adolescence: an expert position statement.

Authors:  Giuseppe Saggese; Francesco Vierucci; Annemieke M Boot; Justyna Czech-Kowalska; Giovanna Weber; Carlos A Camargo; Eric Mallet; Margherita Fanos; Nick J Shaw; Michael F Holick
Journal:  Eur J Pediatr       Date:  2015-04-02       Impact factor: 3.183

Review 5.  Vitamin D in pediatric age: consensus of the Italian Pediatric Society and the Italian Society of Preventive and Social Pediatrics, jointly with the Italian Federation of Pediatricians.

Authors:  Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello
Journal:  Ital J Pediatr       Date:  2018-05-08       Impact factor: 2.638

Review 6.  Clinical review: The role of the parent compound vitamin D with respect to metabolism and function: Why clinical dose intervals can affect clinical outcomes.

Authors:  Bruce W Hollis; Carol L Wagner
Journal:  J Clin Endocrinol Metab       Date:  2013-10-08       Impact factor: 5.958

7.  Vitamin D deficiency is associated with mortality and adverse vascular access outcomes in patients with end-stage renal disease.

Authors:  Joy P Walker; Jade S Hiramoto; Warren J Gasper; Philip Auyang; Michael S Conte; Joseph H Rapp; David H Lovett; Christopher D Owens
Journal:  J Vasc Surg       Date:  2014-02-28       Impact factor: 4.268

8.  Vitamin D is a regulator of endothelial nitric oxide synthase and arterial stiffness in mice.

Authors:  Olena Andrukhova; Svetlana Slavic; Ute Zeitz; Sabine C Riesen; Monika S Heppelmann; Tamas D Ambrisko; Mato Markovic; Wolfgang M Kuebler; Reinhold G Erben
Journal:  Mol Endocrinol       Date:  2013-01-01

9.  Effects of vitamin D supplementation on cardiometabolic outcomes in children and adolescents: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Hanne Hauger; Rikke Pilmann Laursen; Christian Ritz; Christian Mølgaard; Mads Vendelbo Lind; Camilla Trab Damsgaard
Journal:  Eur J Nutr       Date:  2020-02-14       Impact factor: 5.614

Review 10.  Interventions for Prevention and Control of Epidemic of Vitamin D Deficiency.

Authors:  Raman Kumar Marwaha; Aashima Dabas
Journal:  Indian J Pediatr       Date:  2019-01-16       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.